Company

Phragma Therapeutics

Biotechnology Research Boston, United States 6 employees

Employees: 6
Contacts: 1
Emails: 1

phragmatx.com LinkedIn

Phragma Therapeutics Overview

Headquarters: Boston, United States
Website: phragmatx.com
Industry: Biotechnology Research
Employees: 6
Founded: 2023
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Thera Phragma

About Phragma Therapeutics

Phragma Therapeutics is dedicated to advancing treatments for neurological and neurodegenerative diseases through innovative strategies to restore blood-brain barrier (BBB) integrity. Focused on conditions like Alzheimer’s and Parkinson’s, we develop targeted therapies to strengthen CNS barriers. Our subsidiary, Thera Phragma in Greece, extends our research efforts, driving global impact with local expertise. "Phragma" derives from the Greek word "φραγμός", signifying "barrier," reflecting our mission at Phragma to address barriers in both the brain and broader scientific challenges.

Phragma Therapeutics Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage

Phragma Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Maddie Lemieux, Phd	Scientist - Neurodegeneration - Complex	Greater Boston, United States	View
Iosif (Sifis) Pediaditakis	Co-founder & Vice President @ Phragma		View
Spyros Papapetropoulos Md, Phd	President and CEO Neuphoria	Weston, Massachusetts, United States	Email